Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 August 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 207 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 11 results:
Author Title [ Type(Desc)] Year
Filters: Author is Roddy, E.  [Clear All Filters]
Journal Article
L. E. Clarson, Hider, S. L., Belcher, J., Roddy, E., and Mallen, C. D., Factors Influencing Allopurinol Initiation in Primary Care, Ann Fam Med, vol. 15, pp. 557-560, 2017.
A. A. Sultan, Mallen, C., Hayward, R., Muller, S., Whittle, R., Hotston, M., and Roddy, E., Gout and subsequent erectile dysfunction: a population-based cohort study from England, Arthritis Res Ther, vol. 19, p. 123, 2017.
E. Roddy, Muller, S., Paskins, Z., Hider, S. L., Blagojevic-Bucknall, M., and Mallen, C. D., Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink, Medicine (Baltimore), vol. 96, p. e6177, 2017.
L. E. Clarson, Hider, S. L., Belcher, J., Heneghan, C., Roddy, E., and Mallen, C. D., Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink, Ann Rheum Dis, vol. 74, pp. 642-7, 2015.
M. Roughley, Sultan, A. A., Clarson, L., Muller, S., Whittle, R., Belcher, J., Mallen, C. D., and Roddy, E., Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study, Arthritis Res Ther, vol. 20, p. 243, 2018.
Z. Paskins, Whittle, R., Sultan, A. A., Muller, S., Blagojevic-Bucknall, M., Helliwell, T., Hider, S., Roddy, E., and Mallen, C., Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study, BMC Med, vol. 16, p. 4, 2018.
A. A. Sultan, Whittle, R., Muller, S., Roddy, E., Mallen, C. D., Bucknall, M., Helliwell, T., Hider, S., and Paskins, Z., Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy, Cmaj, vol. 190, pp. E581-e587, 2018.
Z. Paskins, Whittle, R., A. Sultan, A., Muller, S., Blagojevic-Bucknall, M., Helliwell, T., Packham, J., Hider, S., Roddy, E., and Mallen, C., Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study, Osteoporos Int, vol. 29, pp. 1659-1664, 2018.
M. Blagojevic-Bucknall, Mallen, C., Muller, S., Hayward, R., West, S., Choi, H., and Roddy, E., The risk of gout among patients with sleep apnea: a matched cohort study, Arthritis Rheumatol, 2018.
A. T. Hancock, Mallen, C. D., Muller, S., Belcher, J., Roddy, E., Helliwell, T., and Hider, S. L., Risk of vascular events in patients with polymyalgia rheumatica, Cmaj, vol. 186, pp. E495-501, 2014.
A. A. Sultan, Muller, S., Whittle, R., Roddy, E., Mallen, C., and Clarson, L., Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy, Cmaj, vol. 191, pp. E597-e603, 2019.
[Page last reviewed 5 August 2020]